A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Clinical trial NCT05796570 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05796570
Sponsor: Franziska Wachter
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Myeloid Malignancies MDS Inherited Bone Marrow Failure Syndrome Myeloid Neoplasm Aml

Start date: 2023-04-19
Primary completion: 2026-08-19
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.